C57BL/6JCya-Pik3caem1flox/Cya
Common Name
Pik3ca-flox
Product ID
S-CKO-04275
Backgroud
C57BL/6JCya
Strain ID
CKOCMP-18706-Pik3ca-B6J-VA
Status
When using this mouse strain in a publication, please cite “Pik3ca-flox Mouse (Catalog S-CKO-04275) were purchased from Cyagen.”
Product Type
Age
Genotype
Sex
Quantity
The standard delivery applies for a guaranteed minimum of three heterozygous carriers. Breeding services for homozygous carriers and/or specified sex are available.
Basic Information
Strain Name
Pik3ca-flox
Strain ID
CKOCMP-18706-Pik3ca-B6J-VA
Gene Name
Product ID
S-CKO-04275
Gene Alias
p110, caPI3K, p110alpha, 6330412C24Rik
Background
C57BL/6JCya
NCBI ID
Modification
Conditional knockout
Chromosome
Chr 3
Phenotype
Datasheet
Application
--
Strain Description
Ensembl Number
ENSMUST00000108243
NCBI RefSeq
NM_008839
Target Region
Exon 5~6
Size of Effective Region
~1.5 kb
Overview of Gene Research
PIK3CA, encoding the catalytic subunit p110α of Class IA Phosphatidylinositol 3-kinases (PI3K), is crucial in signal transduction. It regulates cell cycle, growth, and metabolism via activation of the mTOR1-AKT pathway, which is essential for cell survival and growth [2,3].
Gain-of-function mutations in PIK3CA are associated with various disorders. Somatic activating mutations in PIK3CA are linked to PIK3CA-related overgrowth spectrum (PROS), a group of vascular malformation disorders [1,3,4,5]. In cancer, PIK3CA mutations are prevalent and associated with resistance to first-line treatment and low survival rates in malignancies like colorectal cancer [2,6]. Additionally, in endometrial cancer, PIK3CA exon 9 and/or exon 20 mutations tend to negatively influence survival outcomes [7].
In conclusion, PIK3CA plays a vital role in cell survival, growth, and metabolism through the mTOR1-AKT pathway. Its mutations are associated with a range of disorders, from vascular overgrowth syndromes to malignancies. Understanding PIK3CA is crucial for developing targeted treatments for these diseases.
References：
1. Hughes, Meagan, Hao, Michelle, Luu, Minnelly. . PIK3CA vascular overgrowth syndromes: an update. In Current opinion in pediatrics, 32, 539-546. doi:10.1097/MOP.0000000000000923. https://pubmed.ncbi.nlm.nih.gov/32692051/
2. Hall, Daniella C N, Benndorf, Ralf A. 2022. Aspirin sensitivity of PIK3CA-mutated Colorectal Cancer: potential mechanisms revisited. In Cellular and molecular life sciences : CMLS, 79, 393. doi:10.1007/s00018-022-04430-y. https://pubmed.ncbi.nlm.nih.gov/35780223/
3. Morin, Gabriel M, Zerbib, Lola, Kaltenbach, Sophie, Asnafi, Vahid, Canaud, Guillaume. 2024. PIK3CA-Related Disorders: From Disease Mechanism to Evidence-Based Treatments. In Annual review of genomics and human genetics, 25, 211-237. doi:10.1146/annurev-genom-121222-114518. https://pubmed.ncbi.nlm.nih.gov/38316164/
4. Iriarte Fuster, Adriana, Cerdà Serra, Pau, Riera-Mestre, Antoni. 2021. PIK3CA-related overgrowth spectrum (PROS): new insight in known diseases. In Medicina clinica, 157, 483-488. doi:10.1016/j.medcli.2021.03.036. https://pubmed.ncbi.nlm.nih.gov/34281706/
5. Venot, Quitterie, Canaud, Guillaume. . [PIK3CA-related overgrowth syndrome (PROS)]. In Nephrologie & therapeutique, 13 Suppl 1, S155-S156. doi:10.1016/j.nephro.2017.02.004. https://pubmed.ncbi.nlm.nih.gov/28577738/
6. Willis, Owen, Choucair, Khalil, Alloghbi, Abdurahman, Dworkin, Lance, Nemunaitis, John. 2020. PIK3CA gene aberrancy and role in targeted therapy of solid malignancies. In Cancer gene therapy, 27, 634-644. doi:10.1038/s41417-020-0164-0. https://pubmed.ncbi.nlm.nih.gov/31988478/
7. Bredin, Hanna K, Krakstad, Camilla, Hoivik, Erling A. 2023. PIK3CA mutations and their impact on survival outcomes of patients with endometrial cancer: A systematic review and meta-analysis. In PloS one, 18, e0283203. doi:10.1371/journal.pone.0283203. https://pubmed.ncbi.nlm.nih.gov/36943861/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.